MCL (Mantle-cell lymphoma) and blood cancer (chronic lymphocytic leukemia) are treated with Imbruvica 140mg Capsule. It is also employed in chronic lymphocytic leukaemia who have received at least one previous therapy.
It is advisable to start Imbruvica 140mg Capsule on a daily basis and increase the dose as needed. Your doctor may obtain blood samples to determine the number of blood cells during treatment with this medicine. It is thought to decrease the number of blood cells in your blood, which may increase your vulnerability to infections. An headache, cramp, and nausea might occur as side effects.